Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Bahrami, Fariborz ^a,b   Kukulski, Filip ^a,b   Lecka, Joanna ^a,b   Tremblay, Alain ^b   Pelletier, Julie ^b   Rockenbach, Liliana ^a,b   Sévigny, Jean ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; APYRASE; ECTO 5' NUCLEOTIDASE; INTERLEUKIN 8; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; PHOSPHATASE; PURINERGIC P2 RECEPTOR; PURINERGIC P2Y RECEPTOR; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; 5' NUCLEOTIDASE; ECTOATPASE; PURINE; PURINE DERIVATIVE;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; HT 29 CELL LINE; HUMAN; HUMAN CELL; HYDROLYSIS; INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURINE METABOLISM; METABOLISM; POLYMERASE CHAIN REACTION;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASES; ADENYLATE KINASE; HT29 CELLS; HUMANS; INTERLEUKIN-8; POLYMERASE CHAIN REACTION; PURINES;

EID: 84928391279     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/879895     Document Type: Article

References (64)

1. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation, " Cell, vol. 144, no. 5, pp. 646-674, 2011.
2. M. D. Kappelman, S. L. Rifas-Shiman, K. Kleinman et al. , "The Prevalence andGeographic Distribution of Crohn'sDisease and Ulcerative Colitis in the United States, " Clinical Gastroenterology and Hepatology, vol. 5, no. 12, pp. 1424-1429, 2007.
3. M. D. Kappelman, S. L. Rifas-Shiman, C. Q. Porter et al. , "Direct health care costs of Crohn's disease and ulcerative colitis, " Gastroenterology, vol. 135, no. 6, pp. 1907-1913, 2008.
4. A. Kaser, S. Zeissig, and R. S. Blumberg, "Inflammatory bowel disease, " Annual Review of Immunology, vol. 28, pp. 573-621, 2010.
5. A. M. de Marzo, T. L. DeWeese, E. A. Platz et al. , "Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment, " Journal of Cellular Biochemistry, vol. 91, no. 3, pp. 459-477, 2004.
6. R. B. Gupta, N. Harpaz, S. Itzkowitz et al. , "Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study, " Gastroenterology, vol. 133, no. 4, pp. 1099-1105, 2007.
7. J. K. Triantafillidis, G. Nasioulas, and P. A. Kosmidis, "Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies, " Anticancer Research, vol. 29, no. 7, pp. 2727-2737, 2009.
8. E. Flossmann and P. M. Rothwell, "Effect of aspirin on longterm risk of colorectal cancer: consistent evidence from randomised and observational studies, " The Lancet, vol. 369, no. 9573, pp. 1603-1613, 2007.
9. K. Matsushima, K. Morishita, T. Yoshimura et al. , "Molecular cloning of a human monocyte-derived neutrophil chemotactic factor(MDNCF) and the induction ofMDNCFmRNAby interleukin 1 and tumor necrosis factor, "The Journal of Experimental Medicine, vol. 167, no. 6, pp. 1883-1893, 1988.
10. H. U. Zeilhofer and W. Schorr, "Role of interleukin-8 in neutrophil signaling, " CurrentOpinion inHematology, vol. 7, no. 3, pp. 178-182, 2000.
11. L. Mazzucchelli, C. Hauser, K. Zgraggen et al. , "Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation, " The American Journal of Pathology, vol. 144, no. 5, pp. 997-1007, 1994.
12. M. C. Grimm, S. K. O. Elsbury, P. Pavli, and W. F. Doe, "Interleukin 8: cells of origin in inflammatory bowel disease, " Gut, vol. 38, no. 1, pp. 90-98, 1996.
13. L. M. Campbell, P. J. Maxwell, and D. J. J. Waugh, "Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer, " Pharmaceuticals, vol. 6, no. 8, pp. 929-959, 2013.
14. N. de la Iglesia, G. Konopka, K. Lim et al. , "Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness, " Journal of Neuroscience, vol. 28, no. 23, pp. 5870-5878, 2008.
15. P. Zarogoulidis, F. Katsikogianni, T. Tsiouda, A. Sakkas, N. Katsikogiannis, and K. Zarogoulidis, "Interleukin-8 and interleukin-17 for cancer, " Cancer Investigation, vol. 32, no. 5, pp. 197-205, 2014.
16. F. Kukulski, F. B. Yebdri, J. Lefebvre, M. Warny, P. A. Tessier, and J. Sévigny, "Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo, " Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1269-1275, 2007.
17. F. Kukulski, F. Ben Yebdri, J. Lecka et al. , "Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration, " Cytokine, vol. 46, no. 2, pp. 166-170, 2009.
18. F. B. Yebdri, F. Kukulski, A. Tremblay, andJ. Sévigny, "Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion, " European Journal of Immunology, vol. 39, no. 10, pp. 2885-2894, 2009.
19. F. Di Virgilio, "Purinergic mechanism in the immune system: a signal of danger for dendritic cells, " Purinergic Signalling, vol. 1, no. 3, pp. 205-209, 2005.
20. A. Trautmann, "Extracellular ATP in the immune system: more than just a "danger signal", " Science Signaling, vol. 2, no. 56, article pe6, 2009.
21. G. Y. Chen and G. Nunez, "Sterile inflammation: Sensing and reacting to damage, " Nature Reviews Immunology, vol. 10, no. 12, pp. 826-837, 2010.
22. M. J. L. Bours, E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie, "Adenosine 5-triphosphate and adenosine as endogenous signalingmolecules in immunity and inflammation, " Pharmacology and Therapeutics, vol. 112, no. 2, pp. 358-404, 2006.
23. F. Kukulski, S. A. Lévesque, and J. Sévigny, "Impact of ectoenzymes on P2 and P1 receptor signaling, " Advances in Pharmacology, vol. 61, pp. 263-299, 2011.
24. S. C. Robson, J. Sévigny, and H. Zimmermann, "The ENTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance, " Purinergic Signalling, vol. 2, no. 2, pp. 409-430, 2006.
25. A. R. Beaudoin, J. Sévigny, and M. Picher, "ATP-diphosphohydrolases, apyrases, and nucleotide phosphohydrolases: biochemical properties and functions, " in ATPases, A. G. Lee, Ed. , pp. 369-401, JAI Press, Greenwich, UK, 1996.
26. H. Zimmermann, M. Zebisch, and N. Sträter, "Cellular function and molecular structure of ecto-nucleotidases, " Purinergic Signalling, vol. 8, no. 3, pp. 437-502, 2012.
27. Q. Lu and M. Inouye, "Adenylate kinase complements nucleoside diphosphate kinase deficiency in nucleotide metabolism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 5720-5725, 1996.
28. S. James and P. J. Richardson, "Production of adenosine from extracellular ATP at the striatal cholinergic synapse, " Journal of Neurochemistry, vol. 60, no. 1, pp. 219-227, 1993.
29. G. G. Yegutkin, "Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1783, no. 5, pp. 673-694, 2008.
30. M. T. Abreu-Martin, A. Vidrich, D. H. Lynch, and S. R. Targan, "Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF- and ligation of Fas antigen, " Journal of Immunology, vol. 155, no. 9, pp. 4147-4154, 1995.
31. C. P. Kelly, S. Keates, D. Siegenberg, J. K. Linevsky, C. Pothoulakis, and H. R. Brady, "IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells, " The American Journal of Physiology, vol. 267, no. 6, pp. G991-G997, 1994.
32. T. A. Schneeman, M. E. C. Bruno, H. Schjerven, F. Johansen, L. Chady, and C. S. Kaetzel, "Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4: linking innate and adaptive immune responses, " Journal of Immunology, vol. 175, no. 1, pp. 376-384, 2005.
33. M. Höpfner, K. Lemmer, A. Jansen et al. , "Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells, " Biochemical and Biophysical Research Communications, vol. 251, no. 3, pp. 811-817, 1998.
34. M. Höpfner, K. Maaser, B. Barthel et al. , "Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calciumand cyclic adenosine monophosphate, " International Journal of Colorectal Disease, vol. 16, no. 3, pp. 154-166, 2001.
35. H. Hu, L. M. O'Mullane, M. M. Cummins et al. , "Negative regulation of Ca2+ influx during P2Y2 purinergic receptor activation is mediated by G-subunits, " Cell Calcium, vol. 47, no. 1, pp. 55-64, 2010.
36. M. Sakowicz-Burkiewicz, A. Kitowska, M. Grden, I. Maciejewska, A. Szutowicz, and T. Pawelczyk, "Differential effect of adenosine receptors on growth of human colon cancerHCT 116 and HT-29 cell lines, " Archives of Biochemistry and Biophysics, vol. 533, no. 1-2, pp. 47-54, 2013.
37. T. Ren, Y. Qiu, andW. Wu, "Activation of adenosine A3 receptor alleviates TNF-induced inflammation through inhibition of the NF-B signaling pathway in human colonic epithelial cells, " Mediators of Inflammation, vol. 2014, Article ID818251, 11 pages, 2014.
38. S. Merighi, A. Benini, P. Mirandola et al. , "Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells, " Molecular Pharmacology, vol. 72, no. 2, pp. 395-406, 2007.
39. V. Lelièvre, J. Muller, and J. Falcòn, "Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines, " European Journal of Pharmacology, vol. 341, no. 2-3, pp. 299-308, 1998.
40. V. Lelièvre, E. Caigneaux, J. Muller, and J. Falcón, "Extracellular adenosine deprivation induces epithelial differentiation of HT29 cells: Evidence for a concomitant adenosineA1/A2 receptor balance regulation, " European Journal of Pharmacology, vol. 391, no. 1-2, pp. 21-29, 2000.
41. J. Linden, "Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway", " The American Journal of Physiology-Cell Physiology, vol. 291, no. 3, pp. C405-C406, 2006.
42. S. Gessi, S. Merighi, K. Varani et al. , "Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype, " Journal of Cellular Physiology, vol. 211, no. 3, pp. 826-836, 2007.
43. F. Kukulski, S. A. Lévesque, E. G. Lavoie et al. , "Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8, " Purinergic Signalling, vol. 1, no. 2, pp. 193-204, 2005.
44. S. P. Colgan, H. K. Eltzschig, T. Eckle, and L. F. Thompson, "Physiological roles for ecto-5-nucleotidase (CD73), " Purinergic Signalling, vol. 2, no. 2, pp. 351-360, 2006.
45. N. Sträter, "Ecto-5-nucleotidase: structure function relationships, " Purinergic Signalling, vol. 2, no. 2, pp. 343-350, 2006.
46. L. Collavin, D. Lazarevi?c, R. Utrera, S. Marzinotto, M. Monte, and C. Schneider, "wt p53 dependent expression of a membrane-associated isoform of adenylate kinase, " Oncogene, vol. 18, no. 43, pp. 5879-5888, 1999.
47. M. Wirth, E. Berthold, M. Grashoff, H. Pfutzner, U. Schubert, and H. Hauser, "Detection of mycoplasma contaminations by the polymerase chain reaction, " Cytotechnology, vol. 16, no. 2, pp. 67-77, 1994.
48. J. Pelletier, E. G. Lavoie, M. Fausther et al. , "Production d'anticorps contre les NTPDases, " 9e journeé scientifique du CRRI. Hôtel-Museé Premières Nations, Wendake, Canada, Cahier des résumés, p. 31, 2010.
49. J. Lecka, M. S. Rana, and J. Sévigny, "Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation, " British Journal of Pharmacology, vol. 161, no. 5, pp. 1150-1160, 2010.
50. X. Liu, L. Yu, Q. Wang et al. , "Expression of ecto-ATPase NTPDase2 in human dental pulp, " Journal of Dental Research, vol. 91, no. 3, pp. 261-267, 2012.
51. M. N. Munkonda, J. Pelletier, V. V. Ivanenkov et al. , "Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3: partial characterization of the inhibitory epitope and potential applications, " FEBS Journal, vol. 276, no. 2, pp. 479-496, 2009.
52. A. A. Baykov, O. A. Evtushenko, and S. M. Avaeva, "Amalachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay, " Analytical Biochemistry, vol. 171, no. 2, pp. 266-270, 1988.
53. J. Vaz and R. Andersson, "Intervention on toll-like receptors in pancreatic cancer, " World Journal of Gastroenterology, vol. 20, no. 19, pp. 5808-5817, 2014.
54. B. Fernandez-Garcia, N. Eiró, S. González-Reyes et al. , "Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer, " Journal of Immunotherapy, vol. 37, no. 2, pp. 77-83, 2014.
55. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, " Cell, vol. 118, no. 2, pp. 229-241, 2004.
56. W. Strober, "Epithelial cells pay a Toll for protection, " Nature Medicine, vol. 10, no. 9, pp. 898-900, 2004.
57. M. Vijay-Kumar, H. Wu, J. Aitken et al. , "Activation of tolllike receptor 3 protects against DSS-induced acute colitis, " Inflammatory Bowel Diseases, vol. 13, no. 7, pp. 856-864, 2007.
58. R. Zhou, H. Wei, R. Sun, J. Zhang, and Z. Tian, "NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 18, pp. 7512-7515, 2007.
59. A. E. Ostvik, A. Granlund, B. I. Gustafsson et al. , "Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 20, no. 6, pp. 995-1003, 2014.
60. M. Picher and R. C. Boucher, "Human airway ecto-adenylate kinase: a mechanism to propagate ATP signaling on airway surfaces, " Journal of Biological Chemistry, vol. 278, no. 13, pp. 11256-11264, 2003.
61. T. Henttinen, S. Jalkanen, and G. G. Yegutkin, "Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5-nucleotidase/CD73-dependent mechanism, " Journal of Biological Chemistry, vol. 278, no. 27, pp. 24888-24895, 2003.
62. J. Linden, "Adenosine in tissue protection and tissue regeneration, " Molecular Pharmacology, vol. 67, no. 5, pp. 1385-1387, 2005.
63. M. P. Abbracchio and S. Ceruti, "P1 receptors and cytokine secretion, " Purinergic Signalling, vol. 3, no. 1-2, pp. 13-25, 2007.
64. R. Kruse, I. Demirel, S. Säve, and K. Persson, "IL-8 and global gene expression analysis define a key role of ATP in renal epithelial cell responses induced by uropathogenic bacteria, " Purinergic Signal, 2014.